Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension.

@article{Beghetti2009EisenmengerSA,
  title={Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension.},
  author={Maurice Beghetti and Nazzereno Gali{\`e}},
  journal={Journal of the American College of Cardiology},
  year={2009},
  volume={53 9},
  pages={733-40}
}
Eisenmenger syndrome (ES), the most advanced form of pulmonary arterial hypertension (PAH) associated with congenital heart disease, is a devastating condition that has a considerable impact on patients' lives. Patients who develop ES typically exhibit 1 or more of a range of cardiac defects, including ventricular septal defects, atrial septal defects, and patent ductus arteriosus. The nature of the congenital defect underlying ES is important because it has prognostic implications. Although ES… CONTINUE READING
56 Citations
68 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 56 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 68 references

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan : results of the EARLY study

  • N Galiè, LJ Rubin, MM Hoeper
  • Lancet
  • 2008

Effects of sildenafil treatment in patients with pulmonary hypertension associated with congenital cardiac shunts ( abstr )

  • M Palazzini, A Manes, S Romanazzi
  • Eur Heart J
  • 2007

Similar Papers

Loading similar papers…